Pharmaceutical Industry

Page 13 of 100

Pascal Soriot, chief executive officer of AstraZeneca Plc.
Retail

AstraZeneca sets bold revenue target as CEO aims to double sales to $80 billion by 2030

By Ashleigh Furlong and Bloomberg
May 21, 2024
woman shows off old oversized jeans
Health

Hims will follow its Viagra playbook and offer weight-loss drugs that are 85% cheaper than Wegovy—with Mounjaro and Zepbound in its sights next

By Madison Muller, Jessica Nix and Bloomberg
May 20, 2024
woman measures her waist
Health

Weaning off Ozempic slowly instead of quitting abruptly can help prevent patients from regaining weight, study says

By Ashleigh Furlong and Bloomberg
May 12, 2024
Good DeepMind CEO Demis Hassabis and John Jumper, the scientist who heads the company's protein structure team, accepting a Breakthrough Pirze for their work on AlphaFold 2.
Tech

Google DeepMind and Isomorphic Labs reveal AI able to predict large swathes of molecular biology

By
May 8, 2024
Insulin injection pen
Newsletters

How the CFOs of Eli Lilly and Novo Nordisk are coping with ‘unprecedented demand’ for weight-loss drugs

By
May 3, 2024
Moderna CEO Stéphane Bancel at an event to encourage people to get updated COVID-19 booster shots on September 20, 2023 in Washington, DC.
Health

Moderna’s sales from its only product, the COVID-19 vaccine, fell 91% from last year

By
May 2, 2024
Johnson & Johnson’s latest gambit to solve its massive talcum powder asbestos issue: A $6.5 billion settlement, paid out over 25 years
Finance

Johnson & Johnson’s latest gambit to solve its massive talcum powder asbestos issue: A $6.5 billion settlement, paid out over 25 years

By
May 1, 2024
AMR is on track to lower global life expectancy by an average 1.8 years by 2035, according to a new report from the Global Leaders Group on Antimicrobial Resistance.
Health

Superbugs could lower your life expectancy by nearly 2 years, report says. What to know about antimicrobial resistance

By
April 26, 2024
A scientist in a lab coat peers into a microscope in a lab.
Newsletters

AI for drug discovery draws a $1 billion launch—and a lot of hope

By
April 25, 2024
Bill Anderson, chief executive officer of Bayer
Leadership

Pharmaceutical giant Bayer’s manager cull will likely affect thousands of bosses—and the aspirin inventor thinks it will help its ‘brilliant’ Gen Z grads to thrive

By
April 24, 2024
How Moderna’s CIO helps steer the drugmaker’s post-COVID evolution
Newsletters

How Moderna’s CIO helps steer the drugmaker’s post-COVID evolution

By
April 17, 2024
Bill Anderson, chief executive officer of Bayer
Leadership

Pharmaceutical giant Bayer is getting rid of bosses and asking nearly 100,000 workers to ‘self-organize’ to save $2.15 billion

By
April 11, 2024
Pascal Soriot, chief executive officer of Astrazeneca Plc, arrives at the CEO council at the Great Hall of the People in Beijing, Chin
Success

Major investors say AstraZeneca boss is ‘massively underpaid’ on $21.5 million salary, despite earning more than double Novo Nordisk’s CEO

By
April 10, 2024
Many cancer drugs remain unproven 5 years after accelerated approval, a study finds
Health

Many cancer drugs remain unproven 5 years after accelerated approval, a study finds

By Carla K. Johnson and The Associated Press
April 8, 2024
ALS drug will be pulled from US market after study showed patients didn’t benefit
Health

ALS drug will be pulled from US market after study showed patients didn’t benefit

By Matthew Perrone and The Associated Press
April 4, 2024

Most Popular